Health

AI ยท 251 companies ยท 437 deals tracked
251 Companies
437 Deals Tracked
AI Sector

Health Companies

Eight Sleep Eight Sleep ๐Ÿ‡บ๐Ÿ‡ธ Tebra Tebra ๐Ÿ‡บ๐Ÿ‡ธ Brainomix Brainomix ๐Ÿ‡ฌ๐Ÿ‡ง Scripta Therapeutics Scripta Therapeutics ๐Ÿ‡ฌ๐Ÿ‡ง Bit.bio Bit.bio ๐Ÿ‡ฌ๐Ÿ‡ง Antiverse Antiverse ๐Ÿ‡ฌ๐Ÿ‡ง Medpal Medpal ๐Ÿ‡ฌ๐Ÿ‡ง relation relation ๐Ÿ‡ฌ๐Ÿ‡ง Carna Health Carna Health ๐ŸŒ Holo Holo ๐Ÿ‡ช๐Ÿ‡ธ

Latest Deals in Health

$6.2424M
Oxford Medical Simulation (OMS), a UK startup, has raised โ‚ฌ5.78 million (ยฃ5 million) in growth funding from Salica Investments. The funding will enable OMS to expand into U.S. health systems and invest in AI-driven training solutions, enhancing clinical training effectiveness. Founded in 2017, OMS provides virtual reality healthcare training, allowing clinicians and students to practice realistic scenarios. Salica's investment supports OMS's mission to improve healthcare training outcomes.
Investors: Salica Investments
Health Mar 16, 2026
$4.5M
Ternary Therapeutics, a London-based biotech startup, has raised ยฃ3.6 million in seed funding to develop an AI platform for creating 'molecular glues'โ€”medicines targeting previously 'undruggable' proteins. The investment was led by Daphni, with participation from Pace Ventures, the I&I Biotech Fund, and the UK Innovation & Science Seed Fund. Ternary aims to systematically design these drugs using machine learning and physics-based modeling, addressing a significant challenge in drug discovery.
Investors: Daphni, Pace Ventures, I&I Biotech Fund, UK Innovation & Science Seed Fund
Health Mar 16, 2026
$3.24M
Scinus Group, a Utrecht-based startup, has secured a โ‚ฌ3 million strategic investment led by Myosotis Investments to accelerate the global rollout of its Osilaris cell expansion platform. This funding addresses the critical challenge of scalable cell therapy manufacturing, enhancing production consistency and reducing contamination risks. The platform is already deployed at leading academic and contract development organizations across Europe. With this investment, Scinus aims to strengthen its governance and operational capabilities while executing its commercial rollout strategy.
Investors: Myosotis Investments
Health Mar 16, 2026
$33M
Waiv, a Paris-based developer of AI-powered precision oncology testing technology, has raised $33 million in financing to accelerate the global deployment of its AI precision testing platform and expand its clinical-grade diagnostic offerings.
Health Mar 12, 2026
$33M
Waiv, a spinout from Owkin, has secured $33 million in financing led by OTB Ventures and Alpha Intelligence Capital. The company focuses on AI-powered precision testing to enhance patient identification and stratification in clinical settings and trials. Leveraging a decade of medical AI research, Waiv aims to improve patient care through diagnostics that predict biomarkers and outcomes, collaborating with pharmaceutical firms like MSD on cancer initiatives.
Investors: OTB Ventures, Alpha Intelligence Capital
Health Mar 12, 2026
$33M
Waiv, a Paris, France-based company specializing in AI precision testing, raised $33 million in funding. The round was led by OTB Ventures and Alpha Intelligence Capital, with participation from Serena Data Ventures, Karista, and Sistafund. The funds will be used to expand its portfolio of clinical-grade multimodal tests and enhance pharmaceutical integrations across R&D.
Investors: OTB Ventures, Alpha Intelligence Capital, Serena Data Ventures, Karista, Sistafund
Health Mar 12, 2026
$33M
Waiv, a Paris-based medical testing startup spun out of Owkin, has raised $33 million in a funding round co-led by OTB Ventures and Alpha Intelligence Capital. The company aims to revolutionize cancer screening through AI-powered precision testing. With this funding, Waiv plans to expand its portfolio of clinical tests and deepen partnerships with pharmaceutical companies. The round also saw participation from Serene Data Ventures, Karista, and SistaFund.
Investors: OTB Ventures, Alpha Intelligence Capital, Serene Data Ventures, Karista, SistaFund
Health Mar 12, 2026
$33M
Waiv has secured $33 million in funding led by OTB Ventures and Alpha Intelligence Capital, with participation from Serena Data Ventures, Karista, and Sistafund. The investment will enhance their AI-powered precision tests for oncology, such as RLAPSRisk BC and BRCAura, which provide rapid results and aim to improve clinical trials and patient outcomes. CEO Meriem Sefta leads the company, which leverages a decade of medical AI research and aims to expand globally.
Investors: OTB Ventures, Alpha Intelligence Capital, Serena Data Ventures, Karista, Sistafund
Health Mar 12, 2026
$0.27M
Bliss, a mental health startup headquartered in Finland and originally founded in Albania, has raised $270,000 in angel funding led by Keiretsu Forum, Finest Love VC, and Plug and Play. The funding will support the development of AI infrastructure for culturally aware therapy services, addressing the needs of over 800 million people living outside their country of origin. Bliss focuses on clinician-supervised solutions that combine licensed therapists with AI-driven cultural and linguistic matching, aiming to enhance mental health care for diverse communities.
Investors: Keiretsu Forum, Finest Love VC, Plug and Play
Health Mar 12, 2026
$108M
Alan has raised โ‚ฌ100 million ($116 million) in a funding round led by Index Ventures, increasing its valuation to โ‚ฌ5 billion. The company, which provides health insurance and wellness solutions, aims to address the growing demand for accessible healthcare. With over one million members and โ‚ฌ785 million in annual recurring revenue, Alan is targeting โ‚ฌ1 billion ARR by 2026. Notable investors include Tobi Lรผtke and Antoine Griezmann, and the company is focusing on international expansion and AI integration.
Investors: Tobi Lรผtke, Antoine Griezmann
Health Mar 12, 2026
$1.75M
Spotlight Pathology has raised ยฃ1.4 million in seed funding to enhance its AI software for analyzing digital pathology images, aiding clinicians in the faster and more consistent diagnosis of blood cancers. The technology addresses the challenges of rising demand and staff shortages in UK pathology departments. The funding will support regulatory approvals and early clinical trials as the company aims for wider clinical use. Key investors include the UK Innovation and Science Seed Fund, managed by Future Planet Capital.
Investors: UK Innovation and Science Seed Fund, Future Planet Capital
Health Mar 12, 2026
$1.75M
Spotlight Pathology, a UK healthtech company, has raised ยฃ1.4 million in seed investment to develop AI software that analyzes digital pathology images, aiding clinicians in faster and more consistent identification of blood cancers. This technology addresses the challenges of diagnosing blood cancers, which often require multiple reviews by specialists. The investment will help the company gain regulatory approvals and conduct clinical trials, with support from key investors like the UK Innovation and Science Seed Fund.
Investors: UK Innovation and Science Seed Fund
Health Mar 11, 2026
$0.27M
Bliss, a Helsinki, Finland-based developer of a culturally intelligent AI mental health platform, raised $270k in angel funding. The round was led by Keiretsu Forum, Finest Love VC, and Plug and Play, which included both angel capital and non-dilutive grants. The funds will be used to launch its initial therapist-trained AI companions.
Investors: Keiretsu Forum, Finest Love VC, Plug and Play
Health Mar 11, 2026
$0.27M
Mental health startup Bliss, founded in Albania and headquartered in Finland, has raised $270,000 in angel funding led by Keiretsu Forum, Finest Love VC, and Plug and Play. The funding aims to develop AI infrastructure for culturally aware therapy services, addressing the needs of over 800 million people living outside their country of origin. Bliss focuses on clinician-supervised systems that combine licensed therapists with AI-powered cultural matching, differentiating itself from general-purpose AI solutions.
Investors: Keiretsu Forum, Finest Love VC, Plug and Play
Health Mar 11, 2026
Medisolv, a healthcare quality data management company, has acquired Lilac Software, an AI-driven predictive analytics firm. This acquisition enhances Medisolv's capabilities in AI-powered quality intelligence, addressing the challenges of managing complex value-based care models. The deal signifies a strategic move to improve Medicare Advantage stars performance.
Health Mar 11, 2026
$11M
Amigo AI, a platform for building patient-facing clinical agents, has raised $11 million in a Series A funding round led by Madrona, with participation from Optum Ventures. This brings the total funding to $17 million. The company addresses the challenge of deploying safe AI in healthcare, enabling organizations to improve patient outcomes through AI agents that handle clinical workflows. Amigo has completed over three million patient encounters globally without safety incidents, positioning itself as a leader in clinical AI.
Investors: Madrona, Optum Ventures
Health Mar 10, 2026
$21M
Arya, an AI-enabled couples wellness platform, has secured $21 million in growth financing to develop a 'relationship OS' aimed at improving communication and fostering healthier relationships among modern couples. The funding will support its mission to enhance couple dynamics.
Health Mar 10, 2026
$11M
Amigo AI, a platform focused on building and training patient-facing clinical AI agents, has raised $11 million in a Series A funding round led by Madrona, with participation from Optum Ventures. This brings the company's total funding to $17 million, including a previous seed round co-led by General Catalyst and GSV Ventures.
Investors: Madrona, Optum Ventures, General Catalyst, GSV Ventures
Health Mar 10, 2026
$21M
Arya, an AI-based couples wellness platform, has secured $21 million in growth financing, bringing its total funding to $37 million. The company addresses the growing crisis of emotional disconnection in relationships, particularly among the 72 million couples in the United States. Arya aims to create a 'relationship operating system' that enhances intimacy and communication through proactive digital interventions, supported by insights from relationship experts.
Health Mar 10, 2026
$11M
Amigo AI, a New York City-based provider of a platform for building and training patient-facing clinical agents, raised $11 million in Series A funding. The round was led by Madrona with participation from Optum Ventures, bringing the total funding to $17 million, which includes a seed round co-led by General Catalyst and GSV Ventures.
Investors: Madrona, Optum Ventures, General Catalyst, GSV Ventures
Health Mar 10, 2026